SCHEMBL6174307

SCHEMBL6174307

CC(c1ccncc1NS(N)(=O)=O)C1(C(C)c2ccncc2NS(N)(=O)=O)NC(=O)N(c2ccc(OC(F)(F)F)cc2)C1=O

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP2C9 P11712 2/20 0.38
CYP2C19 P33261 2/20 0.38
CYP3A4 P08684 1/20 0.38
GAA P10253 1/20 0.38
ALDH1A1 P00352 1/20 0.38
CCR9 P51686 2/20 0.36
MAPT P10636 2/20 0.35
POLB P06746 1/20 0.34
L3MBTL1 Q9Y468 1/20 0.34
KMT2A Q03164 2/20 0.33
THRB P10828 1/20 0.33
LIPE Q05469 2/20 0.32
AR P10275 1/20 0.31
TRPV1 Q8NER1 1/20 0.31
TP53 P04637 1/20 0.31
PTGS1 P23219 1/20 0.31
PTGS2 P35354 1/20 0.31
NPBWR1 P48145 1/20 0.31
MCHR1 Q99705 1/20 0.31
NAMPT P43490 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6169571 0.90 CYP3A4 (0.35) CYP2C9CYP2C19CYP3A4GAAALDH1A1
SCHEMBL6173283 0.87 CYP3A4 (0.38) CYP2C9CYP2C19CYP3A4GAAALDH1A1
SCHEMBL6178460 0.86 LIPE (0.38) CYP2C9CYP2C19CYP3A4GAAALDH1A1
SCHEMBL6174952 0.86 IGF1R (0.38) CYP2C9CYP2C19CYP3A4GAAALDH1A1
SCHEMBL6172844 0.86 CYP3A4 (0.40) CYP2C9CYP2C19CYP3A4GAAALDH1A1
SCHEMBL6173377 0.85 LIPE (0.34) CYP2C9CYP2C19CYP3A4GAAALDH1A1
SCHEMBL6173454 0.85 CYP2C9 (0.41) CYP2C9CYP2C19CYP3A4GAAALDH1A1
SCHEMBL6173429 0.83 POLB (0.41) CYP2C9CYP2C19CYP3A4GAAALDH1A1
SCHEMBL6175704 0.82 POLB (0.36) CYP2C9CYP2C19CYP3A4GAAALDH1A1
SCHEMBL6173690 0.82 CYP3A4 (0.41) CYP2C9CYP2C19CYP3A4GAAALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1599464-A2 NOVEL CYCLIC UREA DERIVATIVES, PREPARATION METHOD THEREOF AND PHARMACEUTICAL USE OF SAME AS KINASE INHIBITORS Aventis Pharma S.A. (FR) 2005-11-30 EP disclosed
WO-2004070050-A2 CYCLIC UREA DERIVATIVES, PREPARATION METHOD THEREOF AND PHARMACEUTICAL USE OF SAME AS KINASE INHIBITORS AVENTIS PHARMA S.A. (FR) 2004-08-19 WO disclosed